news

August 15, 2019

CHI Franciscan Activates First AI-Powered Hospital Mission Control Center in Washington State

CHI Franciscan announced the launch of its Mission Control Center, focused on enhancing services, optimizing patient care, and increasing its capacity to serve more... Read More
August 9, 2019

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Bayer AG and BlueRock Therapeutics today announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused... Read More
August 9, 2019

Geneia AI-Based Model Improves Personalization and Precision of Health Risk Scores

Geneia, a healthcare analytic solutions and services company that is simplifying the evolution to value-based care, announced today that the Geneia Data Intelligence Lab... Read More
August 9, 2019

MolecularMatch Announces Issuance of US Patent for its Precision Medicine Service

MolecularMatch, a leading clinical informatics company providing Precision Medicine software solutions for oncology, announced today that the United States Patent and Trademark Office has... Read More
August 6, 2019

Genomenon Wins NIH Grant to Develop Micropublications for Genomic Interpretation

Genomenon, Inc., the leading genomic search engine company, announced today that it was awarded a grant by the National Institutes of Health. The Small... Read More
August 2, 2019

Siemens Healthineers, University of Missouri System and University of Missouri Health Care announce formation of new strategic alliance

Siemens Healthineers and the University of Missouri System (UM System), including all four universities, and University of Missouri Health Care (MU Health Care), have... Read More
August 2, 2019

Massive Bio Launches A Hub to Assemble The Largest Artificial Intelligence Enabled Just-In-Time Precision Oncology Clinical Trial Network in The World

Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial matching, announces today its newly developed “Hub”... Read More
August 2, 2019

Sema4 Announces Location of its Second Connecticut Lab; Harbor Landing in Stamford Will Soon Be Home to 300+ Employees

Sema4, a patient-centered health intelligence company, announced the location of the company’s second laboratory space in Connecticut for its genomic testing products and digital... Read More
August 2, 2019

Precision for Medicine launches biospecimen solutions offering with acquisition of ProMedDx and GLAS

Precision for Medicine, part of Precision Medicine Group, announced it has acquired leading biospecimen providers ProMedDx and GLAS, significantly expanding its capabilities and expertise... Read More
August 2, 2019

Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing

Genome Canada, the Ontario Institute for Cancer Research (OICR) and Thermo Fisher Scientific are collaborating to develop a complete solution of targeted next generation... Read More
July 3, 2019

Genomenon Report Reveals Gene Fusion Data a Critical Factor in Cancer Diagnostics and Drug Development

Genomenon has released a research report detailing clinically significant fusion genes reported through April 2019. Fusion genes have long been known to play an... Read More
July 12, 2019

Precision Medicine changing how value is created and delivered in biopharmaceutical and diagnostics industries

Newsweek has released the results of a new report on precision medicine from their Vantage Thought Leadership division. The report, entitled Precision Medicine: Creating... Read More
July 12, 2019

GNS Healthcare Raises $23 Million Led by Cigna Ventures

GNS Healthcare (GNS), a leading precision medicine company, today announced a $23 million Series D fundraising round, led by Cigna Ventures, a strategic corporate... Read More
July 12, 2019

Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment

Agilent Technologies Inc. (NYSE: A) has announced it has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion. With anticipated tax... Read More
July 12, 2019

Be The Match BioTherapies® and Tmunity Announce Collaboration to Support Clinical Trials of Next-Generation Immunotherapies

–Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Tmunity Therapeutics, Inc., a private clinical-stage... Read More
MORE NEWS